Noninvasive positive-pressure ventilation for respiratory failure after extubation
Esteban 2004 trial design and results
Design
Multicentre randomised trial, stopped early after interim analysis
Treatment
Non-invasive positive-pressure ventilation
Control
Standard medical therapy
Population
221 unselected patients who developed respiratory failure after extubation
Follow-up
ICU stay
Primary endpoint
Need for reintubation
Result
Reintubation was needed in 48% of both groups (relative risk with non-invasive ventilation 0.99, 95% CI 0.76 to 1.30). ICU mortality was higher with non-invasive ventilation, 25% versus 14% (relative risk 1.78, 95% CI 1.03 to 3.20, p=0.048), and median time from respiratory failure to reintubation was longer, 12 versus 2.5 hours (p=0.02). The trial was stopped early.
Secondary endpoints
ICU mortality, time from failure to reintubation
Noninvasive positive-pressure ventilation does not prevent the need for reintubation or reduce mortality in unselected patients who have respiratory failure after extubation.
The trial authors, in the published abstract
How it has aged
The reason non-invasive ventilation is used to prevent post-extubation failure rather than to treat it. Time spent on a mask while deteriorating is time not spent intubated, and that delay is the plausible mechanism of harm. Compare Ferrer 2009, which applied it prophylactically to a selected group and found benefit.
Publications
Noninvasive positive-pressure ventilation for respiratory failure after extubation
Esteban A, Frutos-Vivar F, Ferguson ND, et al. Noninvasive positive-pressure ventilation for respiratory failure after extubation. N Engl J Med 2004 Jun 10;350(24):2452-60.
No reduction in reintubation
Higher ICU mortality, attributed to delayed reintubation